Real-world disparities between patient- and clinician-reported outcomes: results from a disease-specific program in...

Shannon Lubaczewski¹, Jason Shepherd, Rana Fayyad+1

• ¹Shannon Lubaczewski's, PharmD, MS, 15-year career in the pharmaceutical industry includes diverse experiences such as drug manufacturing and packaging, project management, vendor management, clinical quality auditing, pharmacovigilance auditing, clinical pharmacy, and clinical study management from initial planning through coauthoring of the clinical manuscript. Shannon earned a bachelors degree in pharmacy at the Philadelphia College of Pharmacy and Science. She completed a master's degree in quality assurance and regulatory affairs from Temple University. She also earned a doctorate in pharmacy from the University of the Sciences in Philadelphia. She maintains licensure in the state of Pennsylvania. Jason Shepherd, Project Director, Adelphi Real World, joined Adelphi in 2001 after previous marketing research roles with the Medical Research Council, The Research Business International, and NOP in London. He has worked across many therapy areas and is currently responsible for the Neuroses Disease-Specific Programme for Adelphi Real World. Rana Fayyad, PhD, is a statistician with 20 years in the Pharmaceutical industry. Rana has been an employee of Pfizer Inc. for 14 years and, during her career, worked on multiple therapeutic areas, including cardiovascular, oncology, neuroscience, and ophthalmology, covering phases II-IV, as well as publications, and regulatory responses. Rana obtained her PhD in statistics from Colorado State University. Christine J. Guico-Pabia, MD, MBA, MPH, is a physician executive with diverse health care management experience in pharmaceutical, managed care, public health, and medical delivery environments. Christine has a sustained track record of effectively developing and launching innovative pharmaceutical, medical informatics, and managed care products with particular expertise in neuroscience and women's health. She joined Wyeth Pharmaceuticals, now Pfizer Inc., more than 6 years ago as Director and later as Senior Director, Global Med